References
- Kalisz K, Alessandrino F, Beck R, et al. An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence. Insights Imaging. 2019;10(1):56.
- Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood. 2006;107(1):265–276.
- Crawford DH. Biology and disease associations of Epstein-Barr virus. Phil Trans R Soc Lond B. 2001;356(1408):461–473.
- Brady G, MacArthur GJ, Farrell PJ. Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol. 2007;60(12):1397–1402.
- Mukhtar F, Boffetta P, Risch HA, et al. Survival predictors of Burkitt’s lymphoma in children, adults and elderly in the United States during 2000-2013. Int J Cancer. 2017;140(7):1494–1502.
- Li FY, Chaigne-Delalande B, Su H, et al. XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood. 2014;123(14):2148–2152.
- Ravell J, Otim I, Nabalende H, et al. Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda. Cancer Epidemiol. 2018;52:70–74.
- Ravell J, Chaigne-Delalande B, Lenardo M. X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect. Curr Opin Pediatr. 2014;26(6):713–719.
- Goel MK, Khanna P, Kishore J. Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2010;1(4):274–278.
- Huang H, Liu ZL, Zeng H, et al. Clinicopathological study of sporadic Burkitt lymphoma in children. Chin Med J. 2015;128(4):510–514.
- Cunningham J, Rodríguez M, Messa P. Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients. Clin Kidney J. 2012;5(Suppl 1):i39–i51.
- Gile J, Ruan G, Abeykoon J, et al. Magnesium: the overlooked electrolyte in blood cancers? Blood Rev. 2020;100676.
- Kunutsor SK, Apekey TA, Seddoh D, et al. Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):187–201.
- Naito Y, Sasaki H, Takamatsu Y, et al. Retrospective analysis of treatment outcomes and geriatric assessment in elderly malignant lymphoma patients. JCEH. 2016;56(1):43–49.
- Zhao H, Wang T, Wang Y, et al. Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma. Onco Targets Ther. 2016;9:1795–1799.